New award for metoprolol tartrate tablets with exelan pharmaceuticals, INC. Ordering period is may 8, 2026 to may 7, 2027 with four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79726D0020
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Metoprolol Tartrate Tablets Pre-Solicitation · 36E79725R0071 · Posted Oct 9, 2025
- Last date to order 49% complete
- IDV ceiling
- $13,952,068.15
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Exelan Pharmaceuticals Inc. on May 8, 2026, with a ceiling of $13,952,068.15 for supply of Metoprolol Tartrate Tablets. The contract carries no set-aside designation and incorporates Section 5 of Executive Order 14398 and FAR clause 52.222-90 addressing discrimination and diversity, equity, and inclusion compliance.
Performance occurs at Exelan's primary manufacturing and distribution facility in Boca Raton, Florida, with secondary locations in Cary, North Carolina and Summit, New Jersey as designated by the VA. The originating solicitation (RFP 36E79725R0071) sought an unrestricted, single-source supplier of Metoprolol Tartrate Tablets in three strengths (25 mg, 50 mg, and 100 mg) across multiple package sizes (100, 500, and 1,000 tablets per bottle) to serve the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center through their respective pharmaceutical prime vendor programs. Annual usage estimates range from 2,715 to 174,928 bottles depending on strength and package combination.
The contract runs from May 8, 2026, through May 7, 2027, with four one-year option periods. The NAICS classification is 325412 (Pharmaceutical Preparation Manufacturing). Exelan must provide tablets under a unique NDC number specific to the company, with the company's label as the sole label affixed to the product.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79726D0020?
36E79726D0020 was awarded to Exelan Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on May 8, 2026.
How much is contract 36E79726D0020 worth?
36E79726D0020's own ceiling is $13,952,068.
Who can order from contract 36E79726D0020?
36E79726D0020 is a single award indefinite delivery contract.
Was contract 36E79726D0020 competed?
The extent of competition for 36E79726D0020 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV